| Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial RD McBane II, WE Wysokinski, JG Le‐Rademacher, T Zemla, A Ashrani, ... Journal of thrombosis and haemostasis 18 (2), 411-421, 2020 | 497 | 2020 |
| Anticoagulation in COVID-19: a systematic review, meta-analysis, and rapid guidance from Mayo Clinic RD McBane II, VDT Roldan, AS Niven, RK Pruthi, PM Franco, ... Mayo Clinic Proceedings 95 (11), 2467-2486, 2020 | 124 | 2020 |
| Thromboinflammatory biomarkers in COVID-19: systematic review and meta-analysis of 17,052 patients R Chaudhary, J Garg, DE Houghton, MH Murad, A Kondur, R Chaudhary, ... Mayo Clinic Proceedings: Innovations, Quality & Outcomes 5 (2), 388-402, 2021 | 80 | 2021 |
| Testosterone therapy and venous thromboembolism: a systematic review and meta-analysis DE Houghton, M Alsawas, P Barrioneuvo, M Tello, W Farah, B Beuschel, ... Thrombosis research 172, 94-103, 2018 | 79 | 2018 |
| Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer‐associated venous thromboembolism WE Wysokinski, DE Houghton, AI Casanegra, DT Vlazny, ... American journal of hematology 94 (11), 1185-1192, 2019 | 65 | 2019 |
| Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort DE Houghton, NS Key, NA Zakai, JP Laux, TC Shea, S Moll Leukemia & lymphoma 58 (11), 2573-2581, 2017 | 40 | 2017 |
| Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial RD McBane II, CL Loprinzi, T Zemla, A Tafur, K Sanfilippo, JJ Liu, ... Journal of Thrombosis and Haemostasis, 2024 | 34 | 2024 |
| American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing S Middeldorp, R Nieuwlaat, L Baumann Kreuziger, M Coppens, ... Blood Advances 7 (22), 7101-7138, 2023 | 29 | 2023 |
| Evaluation of direct oral anticoagulant reversal agents in intracranial hemorrhage: a systematic review and meta-analysis R Chaudhary, A Singh, R Chaudhary, M Bashline, DE Houghton, ... JAMA Network Open 5 (11), e2240145-e2240145, 2022 | 28 | 2022 |
| Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19 AK Pasha, RD McBane, R Chaudhary, LJ Padrnos, E Wysokinska, ... Thrombosis research 207, 150-157, 2021 | 28 | 2021 |
| Risk of venous thromboembolism after COVID‐19 vaccination DE Houghton, W Wysokinski, AI Casanegra, LJ Padrnos, S Shah, ... Journal of Thrombosis and Haemostasis 20 (7), 1638-1644, 2022 | 27 | 2022 |
| Apixaban and rivaroxaban in patients with acute venous thromboembolism DM Bott-Kitslaar, RD McBane, AI Casanegra, DE Houghton, DA Froehling, ... Mayo Clinic Proceedings 94 (7), 1242-1252, 2019 | 27 | 2019 |
| Bleeding in patients with gastrointestinal cancer compared with nongastrointestinal cancer treated with apixaban, rivaroxaban, or enoxaparin for acute venous thromboembolism DE Houghton, DT Vlazny, AI Casanegra, N Brunton, DA Froehling, ... Mayo Clinic Proceedings 96 (11), 2793-2805, 2021 | 24 | 2021 |
| Treatment of upper extremity deep vein thrombosis with apixaban and rivaroxaban DE Houghton, AI Casanegra, LG Peterson, J Cochuyt, DO Hodge, ... American journal of hematology 95 (7), 817-823, 2020 | 24 | 2020 |
| Effectiveness and safety of apixaban and rivaroxaban for acute venous thromboembolism therapy in patients with extremes in bodyweight WE Wysokinski, DA Froehling, DE Houghton, RD McBane, DT Vlazny, ... European Journal of Haematology 105 (4), 484-494, 2020 | 21 | 2020 |
| Calf vein thrombosis comparison of outcomes for axial and muscular venous thrombosis W Kuczmik, WE Wysokinski, GK Hesley, DT Vlazny, DE Houghton, ... Thrombosis and haemostasis 121 (02), 216-223, 2021 | 20 | 2021 |
| Hemoglobin levels and coronary heart disease risk by age, race, and sex in the reasons for geographic and racial differences in stroke study (REGARDS) DE Houghton, I Koh, A Ellis, NS Key, DR Douce, G Howard, M Cushman, ... American Journal of Hematology 95 (3), 258-266, 2020 | 18 | 2020 |
| Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC) C Pawlowski, T Wagner, A Puranik, K Murugadoss, L Loscalzo, ... Elife 9, e59209, 2020 | 15 | 2020 |
| Outcome of anticoagulation in isolated distal deep vein thrombosis compared to proximal deep venous thrombosis DT Vlazny, AK Pasha, W Kuczmik, WE Wysokinski, M Bartlett, D Houghton, ... Journal of Thrombosis and Haemostasis 19 (9), 2206-2215, 2021 | 14 | 2021 |
| Thrombosis of atypical location: how to treat patients in the era of direct oral anticoagulants MK Mimier, DT Janczak, RD McBane, DE Houghton, WE Wysokinski Pol Arch Intern Med 128 (10), 604-608, 2018 | 14 | 2018 |
Lisa Baumann KreuzigerInvestigator, Blood Research Institute, Versiti; Associate Professor, MCWVerified email at versiti.org
